Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Labianca

Showing results (31-40 of 166) with videos related to

Pageof 17
Sort By:
Journal of Health Services Research & Policy|January 6, 2000
Evolution of physicians' attitudes towards practice guidelinesR Grilli, R Trisolini, R Labianca, et al.
Epidemiologia E Prevenzione|June 5, 1999
[How have opinions of medical oncologists changed regarding compared guidelines? Findings from two surveys conducted in 1993-1997]R Grilli, R Trisolini, R Labianca, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|November 30, 1979
Levamisole in cancer treatment: modifications in time of cellular immunity. (Preliminary report)G Luporini, P Fraschini, R Labianca, et al.
Lancet (London, England)|April 2, 1977
Carcinoembryonic antigen revisitedG Luporini, P Fraschini, R Labianca, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 18, 2005
Targeted therapy in colorectal cancer: do we know enough?M A Pantaleo, E Palassini, R Labianca, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
Modulated 5-fluorouracil (5-FU) regimens in advanced colorectal cancer: a critical review of comparative studiesR Labianca, A Pessi, G Facendola, et al.
Tumori|February 24, 2001
[Adjuvant chemotherapy in colon cancer: certainties and questions] R Labianca, G D Beretta, M A Pessi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2008
Perioperative or postoperative therapy for resectable gastric cancer?R Labianca, P Sburlati, A Quadri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2006
What is the real benefit of adjuvant chemotherapy in the Adjuvant Navelbine International Trialist Association trial?M Mandalà, C Moro, G Michetti, et al.
Dermatology (Basel, Switzerland)|April 18, 2001
Treatment of classical Kaposi's sarcoma with gemcitabineL Brambilla, R Labianca, S M Ferrucci, et al.
Pageof 17

Showing results (31-40 of 166) with videos related to

Sort By:
Pageof 17
Journal of Health Services Research & Policy|January 6, 2000
Evolution of physicians' attitudes towards practice guidelinesR Grilli, R Trisolini, R Labianca, et al.
Epidemiologia E Prevenzione|June 5, 1999
[How have opinions of medical oncologists changed regarding compared guidelines? Findings from two surveys conducted in 1993-1997]R Grilli, R Trisolini, R Labianca, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|November 30, 1979
Levamisole in cancer treatment: modifications in time of cellular immunity. (Preliminary report)G Luporini, P Fraschini, R Labianca, et al.
Lancet (London, England)|April 2, 1977
Carcinoembryonic antigen revisitedG Luporini, P Fraschini, R Labianca, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 18, 2005
Targeted therapy in colorectal cancer: do we know enough?M A Pantaleo, E Palassini, R Labianca, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
Modulated 5-fluorouracil (5-FU) regimens in advanced colorectal cancer: a critical review of comparative studiesR Labianca, A Pessi, G Facendola, et al.
Tumori|February 24, 2001
[Adjuvant chemotherapy in colon cancer: certainties and questions] R Labianca, G D Beretta, M A Pessi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2008
Perioperative or postoperative therapy for resectable gastric cancer?R Labianca, P Sburlati, A Quadri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2006
What is the real benefit of adjuvant chemotherapy in the Adjuvant Navelbine International Trialist Association trial?M Mandalà, C Moro, G Michetti, et al.
Dermatology (Basel, Switzerland)|April 18, 2001
Treatment of classical Kaposi's sarcoma with gemcitabineL Brambilla, R Labianca, S M Ferrucci, et al.
Pageof 17